Federal Circuit Affirms: Claims Covering Invanz Antibiotic Are Invalid

WASHINGTON, D.C. — A divided Federal Circuit U.S. Court of Appeals on Oct. 26 upheld a Delaware federal judge’s determination that 14 claims of a patented antibiotic are invalid, but a...

Already a subscriber? Click here to view full article